These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 23803167)

  • 1. Long-term prognosis after surgical excision of basal cell carcinoma: a single institutional study in Japan.
    Takenouchi T; Takatsuka S
    J Dermatol; 2013 Sep; 40(9):696-9. PubMed ID: 23803167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation.
    Rodriguez-Vigil T; Vázquez-López F; Perez-Oliva N
    J Am Acad Dermatol; 2007 Jan; 56(1):91-5. PubMed ID: 17190625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical excision of basal cell carcinoma with complete margin control: outcome at 5-year follow-up.
    Wetzig T; Woitek M; Eichhorn K; Simon JC; Paasch U
    Dermatology; 2010; 220(4):363-9. PubMed ID: 20484877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of 256 cases of basal cell carcinoma after either one-step or two-step surgery in a Japanese institution.
    Goto M; Kai Y; Arakawa S; Oishi M; Ishikawa K; Anzai S; Hatano Y; Okamoto O; Katagiri K; Fujiwara S; Shimizu F; Kato A; Shibuya H; Eshima N; Terashi H
    J Dermatol; 2012 Jan; 39(1):68-71. PubMed ID: 21951151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal cell carcinoma in Turkey.
    Tiftikcioğlu YO; Karaaslan O; Aksoy HM; Aksoy B; Koçer U
    J Dermatol; 2006 Feb; 33(2):91-5. PubMed ID: 16556274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia.
    Mehrany K; Weenig RH; Pittelkow MR; Roenigk RK; Otley CC
    Arch Dermatol; 2004 Aug; 140(8):985-8. PubMed ID: 15313816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
    Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
    Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal cell carcinomas: do they need to be followed up?
    Park AJ; Strick M; Watson JD
    J R Coll Surg Edinb; 1994 Apr; 39(2):109-11. PubMed ID: 7520063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term Follow-up of Positive Surgical Margins in Basal Cell Carcinoma of the Face.
    Bozan A; Gode S; Kaya I; Yaman B; Uslu M; Akyildiz S; Apaydin F; Ceylan C; Ozturk G
    Dermatol Surg; 2015 Jul; 41(7):761-7. PubMed ID: 26050215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up.
    Roozeboom MH; Aardoom MA; Nelemans PJ; Thissen MR; Kelleners-Smeets NW; Kuijpers DI; Mosterd K
    J Am Acad Dermatol; 2013 Aug; 69(2):280-7. PubMed ID: 23566914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: A randomised clinical trial with 10 year follow-up.
    van Loo E; Mosterd K; Krekels GA; Roozeboom MH; Ostertag JU; Dirksen CD; Steijlen PM; Neumann HA; Nelemans PJ; Kelleners-Smeets NW
    Eur J Cancer; 2014 Nov; 50(17):3011-20. PubMed ID: 25262378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An assessment of incomplete facial Basal cell carcinoma excision.
    Shah SA; Obaidullah ; Fahimullah
    J Coll Physicians Surg Pak; 2005 Mar; 15(3):149-51. PubMed ID: 15808092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical excision versus curettage plus cryosurgery in the treatment of basal cell carcinoma.
    Kuijpers DI; Thissen MR; Berretty PJ; Ideler FH; Nelemans PJ; Neumann MH
    Dermatol Surg; 2007 May; 33(5):579-87. PubMed ID: 17451581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Narrow-margin excision is a safe, reliable treatment for well-defined, primary pigmented basal cell carcinoma: an analysis of 288 lesions in Japan.
    Ito T; Inatomi Y; Nagae K; Nakano-Nakamura M; Nakahara T; Furue M; Uchi H
    J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1828-31. PubMed ID: 25186070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion.
    Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
    J Am Acad Dermatol; 2005 Sep; 53(3):458-63. PubMed ID: 16112353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incompletely excised basal cell carcinoma: residual tumor rates at Mohs re-excision.
    Palmer VM; Wilson PR
    Dermatol Surg; 2013 May; 39(5):706-18. PubMed ID: 23294110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of basal cell carcinoma in a tertiary hospital in Sarawak, Malaysia.
    Yap FB
    Int J Dermatol; 2010 Feb; 49(2):176-9. PubMed ID: 20465642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
    Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
    J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do basal cell carcinomas recur after complete conventional surgical excision?
    Griffiths RW; Suvarna SK; Stone J
    Br J Plast Surg; 2005 Sep; 58(6):795-805. PubMed ID: 16086990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone.
    Blixt E; Nelsen D; Stratman E
    Dermatol Surg; 2013 May; 39(5):719-25. PubMed ID: 23379543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.